Dr. Smith’s
Dr. Smith's is a U.S. consumer healthcare brand owned by Mission Pharmacal Company, selling zinc oxide-based diaper rash ointment and spray products to parents, caregivers, and pediatric healthcare providers via Amazon and direct e-commerce.
- Company typePrivate
- Founded1952
- HeadquartersLouisville, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Dr. Smith’s does
Dr. Smith's is a consumer healthcare brand specializing in diaper rash treatment and prevention products for infants. The brand is owned and operated by Mission Pharmacal Company, a privately held Texas-incorporated pharmaceutical company headquartered in San Antonio. Founded by pediatrician Dr. Forrest Smith in 1952, the brand's core product is Dr. Smith's Diaper Rash Ointment, a zinc oxide 10% formulation marketed under a proprietary "Moisture Shield Technology" label that combines zinc oxide with beeswax, lanolin, mineral oil, olive oil, paraffin wax, petrolatum, purified water, and thymol iodide. The product line was extended with Dr. Smith's Diaper Rash Spray, offering the same formula in a spray format. Both products are positioned as paraben-free, talc-free, scent-free, phthalate-free, and dye-free.
The brand generates revenue through one-time and repeat consumer purchases via two primary channels: direct-to-consumer e-commerce through its website drsmiths.com (which routes purchases to Amazon) and Amazon's third-party marketplace. Distribution is restricted to U.S. residents per the company's terms of use, with manufacturing conducted in the USA by Mission Pharmacal Company. The target customer base is parents, grandparents, and caregivers of infants, with a secondary segment of pediatric healthcare providers who recommend the product professionally. No pricing is publicly disclosed, no B2B or institutional contracts are evidenced, and the brand operates without disclosed funding, M&A activity, or leadership changes.
The company's competitive positioning rests on a 60+ year heritage, pediatrician-origin credibility, two registered trademarks, and accumulated Amazon customer reviews demonstrating multi-generational consumer loyalty. Mission Pharmacal Company also maintains a wholly-owned subsidiary, BioComp Pharma, Inc., though no further operational detail is disclosed. The brand's strategic posture appears defensive and stewardship-oriented, with no recent expansion, funding, or product development beyond the single product line extension to spray format.
Dr. Smith’s firmographics
Firmographics- Name
- Dr. Smith’s
- Legal name
- Mission Pharmacal Company
- Website
- https://drsmiths.com
- Company type
- Private
- Founded year
- 1952
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dr. Smith's is a U.S. consumer healthcare brand owned by Mission Pharmacal Company, selling zinc oxide-based diaper rash ointment and spray products to parents, caregivers, and pediatric healthcare providers via Amazon and direct e-commerce.
- Ownership category
- akta.pro rank
Dr. Smith’s industry classification
Industry- Product category
- Baby Skincare / Diaper Rash Treatment
- NAICS
- Toilet Preparation Manufacturing (325620), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Diapering & Wipes (Diaper Creams, Wipes) (CRABAJAC)
- akta.pro secondary industry
- Baby Skincare (Lotions, Creams, Oils) (CRABAJAB)
Keywords
Where Dr. Smith’s is headquartered
LocationHeadquarters
- HQ city
- Louisville
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Dr. Smith’s business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Consumer Healthcare Product Sales: One-time and repeat purchase revenue from selling Dr. Smith's Diaper Rash Ointment directly to consumers through e-commerce and online marketplaces. The product is positioned for both treatment and preventive daily use, encouraging repeat purchases.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Dr. Smith’s product offering
Product offeringCore offering
Dr. Smith's develops and sells diaper rash treatment and prevention products for infants and babies under the Mission Pharmacal Company umbrella. The core product is Dr. Smith's Diaper Rash Ointment, a zinc oxide 10% skin protectant formulated with proprietary Moisture Shield Technology that combines the active ingredient with a premium blend of beeswax, lanolin, mineral oil, olive oil, paraffin wax, petrolatum, purified water, and thymol iodide. A companion Diaper Rash Spray offers the same soothing relief in a no-mess spray format for easier application during diaper changes.
Product overview
Dr. Smith's is a baby care product line focused on diaper rash treatment and prevention. The core product is Dr. Smith's Diaper Rash Ointment, a zinc oxide-based skin protectant ointment with Moisture Shield Technology. A companion product, Dr. Smith's Diaper Rash Spray, offers the same active formula in a spray format for easier application. Both products are paraben-free, talc-free, scent-free, phthalate-free, and dye-free, developed by pediatrician Dr. Forrest Smith in the 1950s and now manufactured by Mission Pharmacal Company in San Antonio, TX.
Differentiator
Problem solved
Functional benefit
Products and services
- Dr. Smith's Diaper Rash Ointment Zinc oxide 10% based diaper rash treatment and prevention ointment with proprietary Moisture Shield Technology, combining zinc oxide with beeswax, lanolin, mineral oil, olive oil, paraffin wax, petrolatum, purified water, and thymol iodide. Designed for parents and caregivers of infants to treat and prevent diaper rash, gentle enough for daily use. Paraben-free, talc-free, scent-free, phthalate-free, and dye-free.
- Dr. Smith's Diaper Rash Spray Spray-form version of the Dr. Smith's diaper rash ointment, providing the same soothing relief in a no-mess spray format designed for easier application during diaper changes.
Quantifiable outcome
- Effective treatment of severe diaper rash often overnight
- +2 more outcomes
Companies that use Dr. Smith’s
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles1 record
Dr. Smith’s technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Dr. Smith’s partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AmazoncoreAmazon serves as the primary online retail channel for Dr. Smith's Diaper Rash products, including both the ointment and spray formulations. Products are available for purchase directly through Amazon's marketplace platform with customer review functionality.
Scale indicators2 records
Recent moves4 records
Expansion highlights3 records
Dr. Smith’s competitors and assessment
Company assessmentDirect peers
- Aquaphor Baby: Beiersdorf-owned baby skincare brand offering healing ointment and diaper rash products. Overlaps in diaper area protection with comparable pediatrician-recommended, gentle-formulation positioning.
- A+D (Bayer): Bayer-owned diaper rash ointment brand with zinc oxide and lanolin formulas. Direct head-to-head competitor in mass retail channels with similar pediatric heritage and multi-generational consumer recognition.
- Desitin: Market-leading diaper rash ointment brand owned by Johnson & Johnson, offering zinc oxide formulas in both daily-preventive and maximum-strength treatment variants. Same product category, same customer segment, broader retail distribution.
- Boudreaux's Butt Paste: Direct competitor offering zinc oxide-based diaper rash ointment in similar ointment and cream formats. Targets the same parent/caregiver segment with comparable value proposition (fast-acting rash treatment) and is sold through similar Amazon and retail channels.
- Triple Paste: Premium-tier diaper rash ointment brand with pediatrician-developed formula. Competes directly with Dr. Smith's in the clean, gentle, pediatrician-recommended segment and is often sold alongside Dr. Smith's in retail and Amazon channels.
Broad incumbents
- Johnson's Baby: Mass-market baby care giant (J&J) with broad portfolio including diaper rash products. Operates in same category with much larger scale, distribution, and marketing budget, setting competitive baseline for category positioning.
- Burt's Bees Baby: Clorox-owned baby care line with diaper rash ointment and broader natural baby skincare portfolio. Larger incumbent with overlapping clean-formulation positioning and significantly broader distribution and marketing reach.
- Aveeno Baby: Kenvue (J&J spinoff)-owned baby skincare brand with pediatrician-recommended, oat-based formulations. Overlaps in baby skin protection and eczema/diaper area care targeting same parent segment with broader product portfolio.
Emerging players
- California Baby: Premium, clean-ingredient baby care brand offering diaper rash creams alongside broader baby skincare line. Comparable on the 'clean formulation' differentiator (plant-based, no harsh chemicals) targeting same premium-conscious parent segment.
- Mustela: Premium French baby skincare brand offering diaper creams and broader baby skincare. Comparable pediatrician-recommended, gentle-formulation positioning targeting premium-tier parents.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Dr. Smith’s social profiles
Digital presenceDr. Smith’s financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dr. Smith’s leadership team
Management profileNumber of profiles
Dr. Smith’s subsidiaries and ownership
Company hierarchySubsidiaries1 record
Dr. Smith’s funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dr. Smith’s M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dr. Smith’s
What does Dr. Smith’s do?
Dr. Smith's develops and sells diaper rash treatment and prevention products for infants and babies under the Mission Pharmacal Company umbrella. The core product is Dr. Smith's Diaper Rash Ointment, a zinc oxide 10% skin protectant formulated with proprietary Moisture Shield Technology that combines the active ingredient with a premium blend of beeswax, lanolin, mineral oil, olive oil, paraffin wax, petrolatum, purified water, and thymol iodide. A companion Diaper Rash Spray offers the same soothing relief in a no-mess spray format for easier application during diaper changes.
Is Dr. Smith’s a public or private company?
Dr. Smith’s is a private company. It is classified as corporate owned and is currently operating.
When was Dr. Smith’s founded?
Dr. Smith’s was founded in 1952. It employs 11 to 50 people.
Where is Dr. Smith’s based?
Dr. Smith’s is headquartered in Louisville, United States, in the North America region.
How does Dr. Smith’s make money?
One revenue line is on record: consumer Healthcare Product Sales.
Who are Dr. Smith’s's main competitors?
Direct peers on record are Aquaphor Baby, A+D (Bayer), Desitin, Boudreaux's Butt Paste and Triple Paste. Broad incumbents are Johnson's Baby, Burt's Bees Baby and Aveeno Baby. Emerging players are California Baby and Mustela.
Does Dr. Smith’s have an API?
No public API is recorded for Dr. Smith’s.
What industry is Dr. Smith’s in?
Dr. Smith’s's product category is Baby Skincare / Diaper Rash Treatment. Its primary akta.pro industry code is CRABAJAC, Diapering & Wipes (Diaper Creams, Wipes), with a secondary code of CRABAJAB, Baby Skincare (Lotions, Creams, Oils). Its NAICS code is 325620 and its SIC code is 2844.